IL17A and autoimmune disease: However, under pathological conditions such as autoimmune diseases, the synergy between IL-17A and other pro-inflammatory cytokines – including TNF, IL-1, and IFN-γ – amplifies inflammatory responses, ultimately leading to tissue damage (Griffin et al. 2012).